English
 
Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
  Photodynamic Opening of the Blood–Brain Barrier and the Meningeal Lymphatic System: The New Niche in Immunotherapy for Brain Tumors

Semyachkina-Glushkovskaya, O., Terskov, A., Khorovodov, A., Telnova, V., Blokhina, I., Saranceva, E., Kurths, J. (2022): Photodynamic Opening of the Blood–Brain Barrier and the Meningeal Lymphatic System: The New Niche in Immunotherapy for Brain Tumors. - Pharmaceutics, 14, 12, 2612.
https://doi.org/10.3390/pharmaceutics14122612

Item is

Files

show Files
hide Files
:
semyachkina_2022_pharmaceutics-14-02612-v2.pdf (Publisher version), 5MB
Name:
semyachkina_2022_pharmaceutics-14-02612-v2.pdf
Description:
-
Visibility:
Public
MIME-Type / Checksum:
application/pdf / [MD5]
Technical Metadata:
Copyright Date:
-
Copyright Info:
-

Locators

show

Creators

show
hide
 Creators:
Semyachkina-Glushkovskaya, Oxana1, Author
Terskov, Andrey1, Author
Khorovodov, Alexander1, Author
Telnova, Valeria1, Author
Blokhina, Inna1, Author
Saranceva, Elena1, Author
Kurths, Jürgen2, Author              
Affiliations:
1External Organizations, ou_persistent22              
2Potsdam Institute for Climate Impact Research, ou_persistent13              

Content

show
hide
Free keywords: -
 Abstract: Photodynamic therapy (PDT) is a promising add-on therapy to the current standard of care for patients with glioblastoma (GBM). The traditional explanation of the anti-cancer PDT effects involves the PDT-induced generation of a singlet oxygen in the GBM cells, which causes tumor cell death and microvasculature collapse. Recently, new vascular mechanisms of PDT associated with opening of the blood–brain barrier (OBBB) and the activation of functions of the meningeal lymphatic vessels have been discovered. In this review, we highlight the emerging trends and future promises of immunotherapy for brain tumors and discuss PDT-OBBB as a new niche and an important informative platform for the development of innovative pharmacological strategies for the modulation of brain tumor immunity and the improvement of immunotherapy for GBM.

Details

show
hide
Language(s): eng - English
 Dates: 2022-11-262022-11-26
 Publication Status: Finally published
 Pages: 17
 Publishing info: -
 Table of Contents: -
 Rev. Type: Peer
 Identifiers: DOI: 10.3390/pharmaceutics14122612
MDB-ID: No data to archive
PIKDOMAIN: RD4 - Complexity Science
Organisational keyword: RD4 - Complexity Science
Research topic keyword: Health
Research topic keyword: Nonlinear Dynamics
Model / method: Nonlinear Data Analysis
Working Group: Network- and machine-learning-based prediction of extreme events
OATYPE: Gold Open Access
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: Pharmaceutics
Source Genre: Journal, SCI, Scopus, oa
 Creator(s):
Affiliations:
Publ. Info: -
Pages: - Volume / Issue: 14 (12) Sequence Number: 2612 Start / End Page: - Identifier: CoNE: https://publications.pik-potsdam.de/cone/journals/resource/1999-4923
Publisher: MDPI